Omeprazole-cisapride combination for gastroparesis following radical gastrectomy for gastric cancer: An efficacy and safety analysis

doi:10.4240/wjgs.122614

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

This Article

(0)

(52)

Peer-Review Report of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Nov 27, 2026; 18(11): 122614
Published online Nov 27, 2026. doi: 10.4240/wjgs.122614

Table 2 Clinical efficacy comparison, n (%)

Efficacy	Control group (n = 92)	Research group (n = 106)	χ²	P value
Marked effectiveness	36 (39.13)	55 (51.89)
Effectiveness	32 (34.78)	40 (37.74)
Ineffectiveness	24 (26.09)	11 (10.38)
Overall effectiveness	68 (73.91)	95 (89.62)	8.353	0.004

Full Size Table

Citation: Zhu SL, Gao Q, Liu Y, Cheng KP. Omeprazole-cisapride combination for gastroparesis following radical gastrectomy for gastric cancer: An efficacy and safety analysis. World J Gastrointest Surg 2026; 18(11): 122614
URL: https://www.wjgnet.com/1948-9366/full/v18/i11/122614.htm
DOI: https://dx.doi.org/10.4240/wjgs.122614

Zhu SL, Gao Q, Liu Y, Cheng KP. Omeprazole-cisapride combination for gastroparesis following radical gastrectomy for gastric cancer: An efficacy and safety analysis. World J Gastrointest Surg 2026; 18(11): 122614 [DOI: 10.4240/wjgs.122614]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.